Navigation Links
New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming
Date:10/22/2007

Proprietary, non-olefinic material brings new levels of gloss, depth of

image, and surface durability to high-performance TPO sheet stock

MANSFIELD, Texas, Oct. 22 /PRNewswire/ -- Solvay Engineered Polymers, Inc., has introduced its first adhesive tie-layer material for use in the production of extruded sheet. The new ADDHERE(TM) tie layer is designed specifically to bond an acrylic layer onto a substrate of thermoplastic polyolefin (TPO) for use in thermoforming applications.

Effective bonding of dissimilar materials

The ability of the ADDHERE material to bond simultaneously to both an acrylic and an olefinic layer is a major breakthrough in the production of olefinic sheet stock. "Acrylic films are well understood and widely used across many industries for high gloss, depth of image, and surface durability in decorative applications," explains Eric Short, manager of the thermoforming business unit at Solvay Engineered Polymers. "And engineered polyolefins are likewise valued for their impact resistance, dimensional stability, and low- temperature ductility. But until now, there has been no way to effectively bond these two dissimilar materials in an efficient, in-line process."

ADDHERE adhesive tie layer is a pelletized material that can be co- extruded with a TPO substrate, to which acrylic film rollstock can be laminated in-line. Or sheet producers can tri-extrude each of the three materials - acrylic, tie layer, and TPO - from the melt phase to produce a multi-layer sheet.

New ADDHERE tie layer can be colored and recycled

Color can be introduced into an acrylic/TPO sheet in the opaque tie layer. With the acrylic layer free of pigment, it can provide optimum gloss, depth of image, and scratch resistance. At the same time, the absence of pigment from the TPO substrate means its performance properties can be easily and economically controlled.

Both major forms of scrap produced in the process of producing shee
'/>"/>

SOURCE Solvay Engineered Polymers, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Polymer Molecule Layered On Carb Molecule to Increase Sensitivity
2. Teen Players Urged To Wear Helmets and Gloves to Avoid Sports Injuries
3. Jharkhand Ropes in Private Players for Health Scheme
4. Researchers Uncover Critical Player in Cell Communication
5. Zinc – A New Key Player In Brain Circuitr
6. The Cause Behind Water Polo Players’ Sickness Remains A Myster
7. Body Composition Is Key Player in Controlling Cancer Risks
8. Modified Ligament Surgery Improves Outcomes Players, Athletes
9. OBC Creamy Layer May Be Dropped from Reservations in Institutions
10. Indias Pharmaceutical Industry to Be Global Player: Study
11. Former Official Confesses He Had Sold Steroids to Leading Baseball Players
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...ll that could give a longer lease of life to patie...en given along with chemotherapy drugs. Patients t... lived for an average of an extra nine months long...otere alone, reported the online edition of BBC Ne...
...ts, even after twenty years of its introduction.//...ys of viruses, such as those involved in triggerin...tists have realized there is one stumbling block t...he development of an effective transport system, e...
...’, known to save the day during life-threatening a...t of stock, causing panic amongst medics. Wellin...er is facing a problem with its German manufacture...erruption in the supply of this drug to New Zealan...
...d School of Public Health (HSPH) finds that polio ... a net savings of over $180 billion, even without ...d with avoided fear and suffering. This first stud...efits of polio vaccination appears as part of a sp...
Other Medicine News:Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 2Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 3Health News:Billions of Dollars Saved in U.S. By Polio Vaccination 2
(Date:9/4/2008).../- BioForm Medical,Inc. (N...inical study of,Polidocanol, conducted in Germany ...USSLER & Co. GmbH (Kreussler), successfully met th... FDA as part of a New Drug Application,(NDA) proce...I (Efficacy and safety of,Aethoxysklerol compared ...
(Date:9/4/2008)...Lancet, and Presented at ESC Congress-, PHILADELP...ternational,study, the GISSI Heart Failure (GISSI-...ethyl esters reduced all cause mortality and hospi...nts with chronic heart,failure. These findings are...ancet, and were presented at the European Cardiova...
(Date:9/4/2008)...- Southern Research Institute,today a...IH) has selected,the organization to participate i...ction Center Network (MLPCN). The MLPCN -- a colla...lar Libraries Program which is,designed to benefit... human,genome and validate future targets for drug...
(Date:9/4/2008)...ber 4 /- Axentis Pharma AG has,initia...y and tolerability,of a new therapeutic formulatio...in cystic fibrosis patients. The new formulation a...ered directly to the site of,infection. The forthc...ifferent doses of the new drug. Initial results ar...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare 9271 1Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare 9271 2Hacker Joins Conseco as Senior Vice President and Treasurer 9269 1Torchmark Corporation Announces Fourth Quarter 2007 Earnings Release and Conference Call 9267 1Torchmark Corporation Announces Fourth Quarter 2007 Earnings Release and Conference Call 9267 2Hanger Orthopedic Group Inc Announces 2007 Year End Earnings Release Conference Call 9265 1Hanger Orthopedic Group Inc Announces 2007 Year End Earnings Release Conference Call 9265 2
The SkanWasher 300 is an automatic 96-well microplate washer designed to give reliable, reproducible results, with no cross-contamination between wells, and no carryover from plate to plate. The wash
Finstruments 96 well washer and Cellwasher. Multi-function with touch programmable display.
The Finstrip combines high performance and flexibility with reliability, simplicity and ease of use.
The PW 384 has set a standard for ultra-fast washing in both 384-well and 96-well plates. The instrument not only processes all 384 wells simultaneously, it also enables "Overflow" washing to further
Medicine Products: